49 | Combination Treatment with Novel Bcl2 Inhibitor Sonrotoclax (Bgb?11417) + Zanubrutinib Induces High Rate of Complete Remission in Relapsed/refractory Mantle Cell Lymphoma
No Thumbnail Available
All Authors
Tam,C. S.
Lasica,M.
Soumerai,J. D.
Opat,S. S.
Hoffmann,M. S.
Garc韆?Sanz,R.
Schetelig,J.
Munir,T.
Weinkove,R.
Browett,P.
LTHT Author
Munir, Talha
LTHT Department
Oncology
Haematology
Haematology
Non Medic
Publication Date
2025
Item Type
Article
Language
Subject
Subject Headings
Abstract
Journal
Hematological oncology